Article Details

Akero shares soar as NASH drug succeeds in mid-stage trial | BioPharma Dive

Retrieved on: 2022-09-14 02:55:58

Tags for this article:

Click the tags to see associated articles and topics

Akero shares soar as NASH drug succeeds in mid-stage trial | BioPharma Dive. View article details on hiswai:

Excerpt

Akero Therapeutics' shares more than doubled in early trading on Tuesday after the company said an experimental medicine reduced the internal scarring ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up